Alzheimer’s disease begins long before symptoms show. The ReTain study is evaluating whether an investigational medication is safe, tolerable and effective at slowing the onset of Alzheimer’s disease symptoms for those who may be at risk.
ReTain
Dementia and cognitive impairmentClosed to recruitment
